397 related articles for article (PubMed ID: 31730862)
21. Tumor-stroma biomechanical crosstalk: a perspective on the role of caveolin-1 in tumor progression.
Lolo FN; Jiménez-Jiménez V; Sánchez-Álvarez M; Del Pozo MÁ
Cancer Metastasis Rev; 2020 Jun; 39(2):485-503. PubMed ID: 32514892
[TBL] [Abstract][Full Text] [Related]
22. Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions.
Alexander J; Cukierman E
Curr Opin Cell Biol; 2016 Oct; 42():80-93. PubMed ID: 27214794
[TBL] [Abstract][Full Text] [Related]
23. Profiling Cancer-Associated Fibroblasts in Melanoma.
Papaccio F; Kovacs D; Bellei B; Caputo S; Migliano E; Cota C; Picardo M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298873
[TBL] [Abstract][Full Text] [Related]
24. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of the tumor microenvironment: are CAFs the Organizer?
Kochetkova M; Samuel MS
Trends Cell Biol; 2022 Apr; 32(4):285-294. PubMed ID: 34895986
[TBL] [Abstract][Full Text] [Related]
26. Small extracellular vesicle-packaged TGFβ1 promotes the reprogramming of normal fibroblasts into cancer-associated fibroblasts by regulating fibronectin in head and neck squamous cell carcinoma.
Huang Q; Hsueh CY; Shen YJ; Guo Y; Huang JM; Zhang YF; Li JY; Gong HL; Zhou L
Cancer Lett; 2021 Oct; 517():1-13. PubMed ID: 34089808
[TBL] [Abstract][Full Text] [Related]
27. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.
Bu L; Baba H; Yoshida N; Miyake K; Yasuda T; Uchihara T; Tan P; Ishimoto T
Oncogene; 2019 Jun; 38(25):4887-4901. PubMed ID: 30816343
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment.
Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
Front Immunol; 2023; 14():1152312. PubMed ID: 37033960
[TBL] [Abstract][Full Text] [Related]
29. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
30. Significance of the Tumor Microenvironment in Liver Cancer Progression.
Muppala S
Crit Rev Oncog; 2020; 25(1):1-9. PubMed ID: 32865906
[TBL] [Abstract][Full Text] [Related]
31. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
[TBL] [Abstract][Full Text] [Related]
32. A Holistic Appraisal of Stromal Differentiation in Colorectal Cancer: Biology, Histopathology, Computation, and Genomics.
Hacking SM; Chakraborty B; Nasim R; Vitkovski T; Thomas R
Pathol Res Pract; 2021 Apr; 220():153378. PubMed ID: 33690050
[TBL] [Abstract][Full Text] [Related]
33. The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators.
Ilkhani K; Bastami M; Delgir S; Safi A; Talebian S; Alivand MR
Anticancer Agents Med Chem; 2021; 21(2):254-266. PubMed ID: 32914721
[TBL] [Abstract][Full Text] [Related]
34. Modern views on the role of main components of stroma and tumor microinvironment in invasion, migration and metastasis.
Naleskina LA; Kunska LM; Chekhun VF
Exp Oncol; 2020 Dec; 42(4):252-262. PubMed ID: 33355867
[TBL] [Abstract][Full Text] [Related]
35. Metabolic reprogramming of the tumour microenvironment.
Xing Y; Zhao S; Zhou BP; Mi J
FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
[TBL] [Abstract][Full Text] [Related]
36. Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation.
Coleman DT; Gray AL; Stephens CA; Scott ML; Cardelli JA
Oncotarget; 2016 May; 7(22):32200-9. PubMed ID: 27058757
[TBL] [Abstract][Full Text] [Related]
37. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
[TBL] [Abstract][Full Text] [Related]
38. Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins.
Zeltz C; Primac I; Erusappan P; Alam J; Noel A; Gullberg D
Semin Cancer Biol; 2020 May; 62():166-181. PubMed ID: 31415910
[TBL] [Abstract][Full Text] [Related]
39. Metabolic alterations in the tumor microenvironment and their role in oncogenesis.
Eisenberg L; Eisenberg-Bord M; Eisenberg-Lerner A; Sagi-Eisenberg R
Cancer Lett; 2020 Aug; 484():65-71. PubMed ID: 32387442
[TBL] [Abstract][Full Text] [Related]
40. Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling.
Tang X; Hou Y; Yang G; Wang X; Tang S; Du YE; Yang L; Yu T; Zhang H; Zhou M; Wen S; Xu L; Liu M
Cell Death Differ; 2016 Jan; 23(1):132-45. PubMed ID: 26068592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
